Position in OCGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,572,649
+$5,921,592 QoQ
Shares Held
8,871,013
+109.9% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 147 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. OCGN ranks #168 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in OCGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,572,649 | 8,871,013 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,651,057 | 4,227,104 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,155,975 | 3,819,242 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,993,822 | 3,677,192 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,383,166 | 3,487,801 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,863,507 | 6,888,821 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,303,667 | 6,588,407 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,228,325 | 6,278,554 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,152,747 | 5,904,999 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,270,172 | 3,213,520 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,684,720 | 2,929,948 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,144,585 | 2,861,463 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,554,591 | 2,862,968 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,976,117 | 4,661,333 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,386,585 | 4,143,527 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,774,587 | 3,805,948 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,351,570 | 3,679,106 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,385,533 | 2,844,101 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,898,224 | 3,274,335 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $24,101,938 | 3,356,816 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,558,157 | 3,182,834 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $11,102,817 | 1,635,172 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,226,039 | 1,216,415 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $169,055 | 545,340 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $44,128 | 200,583 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $56,363 | 200,583 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||